; Pharma Foods International Co. Company Profile - Aug 20, 2011
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Pharma Foods International Co. Company Profile - Aug 20, 2011

VIEWS: 39 PAGES: 10

Pharma Foods International Co., Ltd. is a Japan-based company mainly engaged in the physiology research, application research and sale of functional food materials. The Company has four business segments. The Functional Material segment provides egg yolk antibodies (IgY), folic acid eggs, gamma-aminobutyric acid (GABA), Bonepep and others. The Functional Product segment is engaged in the research and development of functional materials, as well as the planning and commercialization of final products toward consumers. The Biomedical segment is involved in the research and development of functional materials which focus on egg yolk antibody technology. The Life Science Information (LSI) segment is engaged in the acquisition and analysis of functionality data; the components analysis of various materials; the production of refined products, as well as the provision of research and development support services for food makers and other makers.

More Info
  • pg 1
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Pharma Foods International Co.Ltd
                                                                                       440 Wheelers Farms Road
                                                                                       Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Japanese Yen

                                 Wright Quality Rating:LBNN                                Key Data

   Pharma Foods International Co., Ltd. is a Japan-based company mainly engaged in         Ticker:
   the physiology research, application research and sale of functional food materials.    2929
   The Company has four business segments. The Functional Material segment provides
   egg yolk antibodies (IgY), folic acid eggs, gamma-aminobutyric acid (GABA),             2010 Sales:
   Bonepep and others. The Functional Product segment is engaged in the research and
                                                                                           959,103,000
   development of functional materials, as well as the planning and commercialization of
   final products toward consumers. The Biomedical segment is involved in the research
   and development of functional materials which focus on egg yolk antibody                Major Industry:
   technology. The Life Science Information (LSI) segment is engaged in the acquisition    Food & Beverages
   and analysis of functionality data; the components analysis of various materials; the
   production of refined products, as well as the provision of research and development    Sub Industry:
   support services for food makers and other makers.                                      Miscellaneous Food
                             Stock Chart                                Officers
                                                                       President           Country:
                                                                     Mu Jo Kim (Rep)       Japan

                                                                                           Currency:
                                                                                           Japanese Yen

                                                                                           Fiscal Year Ends:
                                                                                           July

                                                                                           Employees
                                                                                           28

                                                                                           Exchanges:
                                                                                           TYO

                                                                                           Share Type:
                                                                                           Common
               Stock Price (8/12/2011): 18,800.00
                    Recent stock performance                                               Market Capitalization:
                        1 Week       2.2%                                                  1,104,500,000
                        4 Weeks     -2.4%
                        13 Weeks    -7.8%                                                  Total Shares
                        52 Weeks   -17.2%                                                  Ou
								
To top
;